Prior serum- and AICAR-induced AMPK activation in primary human myocytes does not lead to subsequent increase in insulin-stimulated glucose uptake

American Journal of Physiology - Endocrinology and Metabolism

Volumn 287, Issue 3 50-3, 2004, Pages

  Al Khalili, Lubna ^a   Krook, Anna ^a   Zierath, Juleen R ^a   Cartee, Gregory D ^b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

5 aminoimidazole 4 carboxamide 1 D ribofuranoside; AMP activated protein kinase; Exercise; Glucose transport; Skeletal muscle

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ACETYL COENZYME A CARBOXYLASE; DEOXYGLUCOSE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; TRITIUM;

ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; EXERCISE; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MUSCLE BIOPSY; MUSCLE CELL; PRIORITY JOURNAL; SERUM; SKELETAL MUSCLE;

AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; BLOOD; DEOXYGLUCOSE; ENZYME ACTIVATION; GLUCOSE; HUMANS; IMMUNOBLOTTING; INSULIN; MULTIENZYME COMPLEXES; MUSCLE CELLS; MUSCLE, SKELETAL; PROTEIN-SERINE-THREONINE KINASES; RATS; RIBONUCLEOTIDES;

EID: 4143102390     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00161.2004     Document Type: Article

References (29)

1. Al-Khalili L, Cartee GD, and Krook A. RNA interference-mediated reduction in GLUT1 inhibits serum-induced glucose transport in primary human skeletal muscle cells. Biochem Biophys Res Commun 307: 127-132, 2003.
2. Al-Khalili L, Chibalin AV, Kannisto K, Zhang BB, Permert J, Holman GD, Ehrenborg E, Ding VD, Zierath JR, and Krook A. Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content. Cell Mol Life Sci 60: 991-998, 2003.
3. Baque S, Montell E, Camps M, Guinovart JJ, Zorzano A, and Gomez-Foix AM. Overexpression of glycogen phosphorylase increases GLUT4 expression and glucose transport in cultured skeletal human muscle. Diabetes 47: 1185-1192, 1998.
4. Brodie C and Sampson SR. Serum factor induces selective increase in Na-channel expression in cultured skeletal muscle. J Cell Physiol 148: 48-53, 1991.
5. Cartee GD and Holloszy JO. Exercise increases susceptibility of muscle glucose transport to activation by various stimuli. Am J Physiol Endocrinol Metab 258: E390-E393, 1990.
6. Cartee GD, Young DA, Sleeper MD, Zierath J, Wallberg-Henriksson H, and Holloszy JO. Prolonged increase in insulin-stimulated glucose transport in muscle after exercise. Am J Physiol Endocrinol Metab 256: E494-E499, 1989.
7. Chen HC, Bandyopadhyay G, Sajan MP, Kanoh Y, Standaert M, Farese RV Jr, and Farese RV. Activation of the ERK pathway and atypical protein kinase C isoforms in exercise- and aminoimidazole-4-carboxamide-1-beta-D-riboside (AICAR)-stimulated glucose transport. J Biol Chem 277: 23554-23562, 2002.
8. Constable SH, Favier RJ, Cartee GD, Young DA, and Holloszy JO. Muscle glucose transport: interactions of in vitro contractions, insulin, and exercise. J Appl Physiol 64: 2329-2332, 1988.
9. Dumke CL, Kim J, Arias EB, and Cartee GD. Role of kallikrein-kininogen system in insulin-stimulated glucose transport after muscle contractions. J Appl Physiol 92: 657-664, 2002.
10. Fisher JS, Gao J, Han DH, Holloszy JO, and Nolte LA. Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin. Am J Physiol Endocrinol Metab 282: E18-E23, 2002.
11. Gao J, Gulve EA, and Holloszy JO. Contraction-induced increase in muscle insulin sensitivity: requirement for a serum factor. Am J Physiol Endocrinol Metab 266: E186-E192, 1994.
12. Goodyear LJ. AMP-activated protein kinase: a critical signaling intermediary for exercise-stimulated glucose transport? Exerc Sport Sci Rev 28: 113-116, 2000.
13. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, and Goodyear LJ. Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47: 1369-1373, 1998.
14. Henry RR, Abrams L, Nikoulina S, and Ciaraldi TP. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures. Diabetes 44: 936-946, 1995.
15. Holloszy JO and Hansen PA. Regulation of glucose transport into skeletal muscle. Rev Physiol Biochem Pharmacol 128: 99-193, 1996.
16. Kim J, Solis RS, Arias EB, and Cartee GD. Postcontraction insulin sensitivity: relationship with contraction protocol, glycogen concentration, and 5′ AMP-activated protein kinase phosphorylation. J Appl Physiol 96: 575-583, 2004.
17. Koistinen HA, Galuska D, Chibalin AV, Yang J, Zierath JR, Holman GD, and Wallberg-Henriksson H. 5-Amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Diabetes 52: 1066-1072, 2003.
18. Krook A, Moller DE, Dib K, and O'Rahilly S. Two naturally occurring mutant insulin receptors phosphorylate insulin receptor substrate-1 (IRS-1) but fail to mediate the biological effects of insulin. Evidence that IRS-1 phosphorylation is not sufficient for normal insulin action. J Biol Chem 271: 7134-7140, 1996.
19. Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, and Winder WW. 5′ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48: 1667-1671, 1999.
20. Lemieux K, Konrad D, Klip A, and Marette A. The AMP-activated protein kinase activator AICAR does not induce GLUT4 translocation to transverse tubules but stimulates glucose uptake and p38 mitogen-activated protein kinases alpha and beta in skeletal muscle. FASEB J 17: 1658-1665, 2003.
21. Musi N and Goodyear LJ. AMP-activated protein kinase and muscle glucose uptake. Acta Physiol Scand 178: 337-345, 2003.
22. Nesher R, Karl IE, and Kipnis DM. Dissociation of effects of insulin and contraction on glucose transport in rat epitrochlearis muscle. Am J Physiol Cell Physiol 249: C226-C232, 1985.
23. Ryder JW, Yang J, Galuska D, Rincon J, Bjornholm M, Krook A, Lund S, Pedersen O, Wallberg-Henriksson H, Zierath JR, and Holman GD. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes 49: 647-654, 2000.
24. Sakoda H, Ogihara T, Anai M, Fujishiro M, Ono H, Onishi Y, Katagiri H, Abe M, Fukushima Y, Shojima N, Inukai K, Kikuchi M, Oka Y, and Asano T. Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes. Am J Physiol Endocrinol Metab 282: E1239-E1244, 2002.
25. Salt IP, Connell JM, and Gould GW. 5-Aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes. Diabetes 49: 1649-1656, 2000.
26. Sargeant R, Mitsumoto Y, Sarabia V, Shillabeer G, and Klip A. Hormonal regulation of glucose transporters in muscle cells in culture. J Endocrinol Invest 16: 147-162, 1993.
27. Sivitz WI and Pasley AM. Glucocorticoid effects on glucose transport and transporter gene expression in L6 muscle cells. Biochem Biophys Res Commun 206: 51-56, 1995.
28. Somwar R, Sweeney G, Ramlal T, and Klip A. Stimulation of glucose and amino acid transport and activation of the insulin signaling pathways by insulin lispro in L6 skeletal muscle cells. Clin Ther 20: 125-140, 1998.
29. Wallberg-Henriksson H, Constable SH, Young DA, and Holloszy JO. Glucose transport into rat skeletal muscle: interaction between exercise and insulin. J Appl Physiol 65: 909-913, 1988.